Global influenza cases have dramatically increased since the COVID-19 pandemic, likely due to a drop in population immunity.

Corporate and Financial Updates In April 2025, Invivyd secured a $30 million non-dilutive term loan facility with Silicon Valley Bank, a division of First Citizens Bank, supporting balance sheet ...

Vermont has the second lowest state fatality rate in the US (147.2 per 100K; Hawaii 112.9/100K). Mississippi (464.7/100K) and ...

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

The infant mortality national rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to provisional ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

RSV, or respiratory syncytial virus ... whereas a vaccine empowers the body's immune system to produce an immune response, which involves creating antibodies, they said. The findings indicate ...

Respiratory virus data included in the interactive data application is up-to-date as of May 10, 2025. Among its new features, the dashboard now includes RSV Severe Outcomes data.

RSV is a leading cause of serious respiratory illness in young children particularly in the first six months of life, responsible for millions of hospitalisations of children around the world ...